CHRISTOPHER SIPALA: Open Payments
NPI 1487071049 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 30 payments from 7 companies in 2025. Trend: 2023 $1,300 · 2024 $1,393 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 18 | $265 |
| Biosense Webster, Inc. | 2 | $186 |
| Kestra Medical Technology Services, Inc. | 2 | $171 |
| BIOTRONIK INC. | 2 | $170 |
| Boston Scientific Corporation | 2 | $161 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $65 |
| AtriCure, Inc. | 1 | $58 |
Products named: ENSITE, CARTO 3, Assure WCD, BIOMONITOR, WATCHMAN FLX, General - Therapies, JOT DX, LifeVest.
Industry payments across PA — which companies pay providers there.
